BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stec DE, John K, Trabbic CJ, Luniwal A, Hankins MW, Baum J, Hinds TD Jr. Bilirubin Binding to PPARα Inhibits Lipid Accumulation. PLoS One 2016;11:e0153427. [PMID: 27071062 DOI: 10.1371/journal.pone.0153427] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Hinds TD Jr, Stec DE. Bilirubin, a Cardiometabolic Signaling Molecule. Hypertension 2018;72:788-95. [PMID: 30354722 DOI: 10.1161/HYPERTENSIONAHA.118.11130] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
2 Wang S, Lin Y, Zhou Z, Gao L, Yang Z, Li F, Wu B. Circadian Clock Gene Bmal1 Regulates Bilirubin Detoxification: A Potential Mechanism of Feedback Control of Hyperbilirubinemia. Theranostics 2019;9:5122-33. [PMID: 31410205 DOI: 10.7150/thno.35773] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
3 Yao Q, Chen R, Ganapathy V, Kou L. Therapeutic application and construction of bilirubin incorporated nanoparticles. Journal of Controlled Release 2020;328:407-24. [DOI: 10.1016/j.jconrel.2020.08.054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
4 Donegan RK, Moore CM, Hanna DA, Reddi AR. Handling heme: The mechanisms underlying the movement of heme within and between cells. Free Radic Biol Med 2019;133:88-100. [PMID: 30092350 DOI: 10.1016/j.freeradbiomed.2018.08.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
5 Wang D, Tosevska A, Heiß EH, Ladurner A, Mölzer C, Wallner M, Bulmer A, Wagner KH, Dirsch VM, Atanasov AG. Bilirubin Decreases Macrophage Cholesterol Efflux and ATP-Binding Cassette Transporter A1 Protein Expression. J Am Heart Assoc 2017;6:e005520. [PMID: 28455345 DOI: 10.1161/JAHA.117.005520] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
6 Creeden JF, Gordon DM, Stec DE, Hinds TD Jr. Bilirubin as a metabolic hormone: the physiological relevance of low levels. Am J Physiol Endocrinol Metab 2021;320:E191-207. [PMID: 33284088 DOI: 10.1152/ajpendo.00405.2020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
7 Wang F, Chen S, Ren L, Wang Y, Li Z, Song T, Zhang H, Yang Q. The Effect of Silibinin on Protein Expression Profile in White Adipose Tissue of Obese Mice. Front Pharmacol 2020;11:55. [PMID: 32184719 DOI: 10.3389/fphar.2020.00055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Niu JL, Zhang J, Wei LQ, Zhang WJ, Nie CX. Effect of Fermented Cottonseed Meal on the Lipid-Related Indices and Serum Metabolic Profiles in Broiler Chickens. Animals (Basel) 2019;9:E930. [PMID: 31703286 DOI: 10.3390/ani9110930] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Comas F, Latorre J, Ortega F, Arnoriaga Rodríguez M, Lluch A, Sabater M, Rius F, Ribas X, Costas M, Ricart W, Lecube A, Fernández-real JM, Moreno-navarrete JM. Morbidly obese subjects show increased serum sulfide in proportion to fat mass. Int J Obes 2021;45:415-26. [DOI: 10.1038/s41366-020-00696-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Hinds TD Jr, Hosick PA, Chen S, Tukey RH, Hankins MW, Nestor-Kalinoski A, Stec DE. Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα. Am J Physiol Endocrinol Metab 2017;312:E244-52. [PMID: 28096081 DOI: 10.1152/ajpendo.00396.2016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 9.2] [Reference Citation Analysis]
11 Sundararaghavan VL, Binepal S, Stec DE, Sindhwani P, Hinds TD Jr. Bilirubin, a new therapeutic for kidney transplant? Transplant Rev (Orlando) 2018;32:234-40. [PMID: 29983261 DOI: 10.1016/j.trre.2018.06.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
12 Zhang Z, Amorosa LF, Petrova A, Coyle S, Macor M, Nair M, Lee LY, Haimovich B. TLR4 counteracts BVRA signaling in human leukocytes via differential regulation of AMPK, mTORC1 and mTORC2. Sci Rep 2019;9:7020. [PMID: 31065010 DOI: 10.1038/s41598-019-43347-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Coltell O, Asensio EM, Sorlí JV, Barragán R, Fernández-Carrión R, Portolés O, Ortega-Azorín C, Martínez-LaCruz R, González JI, Zanón-Moreno V, Gimenez-Alba I, Fitó M, Ros E, Ordovas JM, Corella D. Genome-Wide Association Study (GWAS) on Bilirubin Concentrations in Subjects with Metabolic Syndrome: Sex-Specific GWAS Analysis and Gene-Diet Interactions in a Mediterranean Population. Nutrients 2019;11:E90. [PMID: 30621171 DOI: 10.3390/nu11010090] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
14 Tsai MT, Tarng DC. Beyond a Measure of Liver Function-Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients. Int J Mol Sci 2018;20:E117. [PMID: 30597982 DOI: 10.3390/ijms20010117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
15 Ceccarelli V, Barchetta I, Cimini FA, Bertoccini L, Chiappetta C, Capoccia D, Carletti R, Di Cristofano C, Silecchia G, Fontana M, Leonetti F, Lenzi A, Baroni MG, Barone E, Cavallo MG. Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity. Int J Mol Sci 2020;21:E9091. [PMID: 33260451 DOI: 10.3390/ijms21239091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Sodhi K, Denvir J, Liu J, Sanabria JR, Chen Y, Silverstein R, Xie Z, Abraham NG, Shapiro JI. Oxidant-Induced Alterations in the Adipocyte Transcriptome: Role of the Na,K-ATPase Oxidant Amplification Loop. Int J Mol Sci 2020;21:E5923. [PMID: 32824688 DOI: 10.3390/ijms21165923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Marino JS, Stechschulte LA, Stec DE, Nestor-Kalinoski A, Coleman S, Hinds TD Jr. Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α. J Biol Chem 2016;291:25776-88. [PMID: 27784782 DOI: 10.1074/jbc.M116.752311] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
18 Ellul C, Shoemake C. Design of Novel Compounds with the Potential of Dual PPARγ/α Modulation for the Management of Metabolic Syndrome. Nuclear Receptor Research 2017;4. [DOI: 10.11131/2017/101311] [Reference Citation Analysis]
19 Hamoud AR, Weaver L, Stec DE, Hinds TD Jr. Bilirubin in the Liver-Gut Signaling Axis. Trends Endocrinol Metab 2018;29:140-50. [PMID: 29409713 DOI: 10.1016/j.tem.2018.01.002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 14.8] [Reference Citation Analysis]
20 Hinds TD Jr, Burns KA, Hosick PA, McBeth L, Nestor-Kalinoski A, Drummond HA, AlAmodi AA, Hankins MW, Vanden Heuvel JP, Stec DE. Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α. J Biol Chem 2016;291:25179-91. [PMID: 27738106 DOI: 10.1074/jbc.M116.731703] [Cited by in Crossref: 60] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
21 Stec DE, Hinds TD Jr. Natural Product Heme Oxygenase Inducers as Treatment for Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2020;21:E9493. [PMID: 33327438 DOI: 10.3390/ijms21249493] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
22 Raffaele M, Pittalà V, Zingales V, Barbagallo I, Salerno L, Li Volti G, Romeo G, Carota G, Sorrenti V, Vanella L. Heme Oxygenase-1 Inhibition Sensitizes Human Prostate Cancer Cells towards Glucose Deprivation and Metformin-Mediated Cell Death. Int J Mol Sci 2019;20:E2593. [PMID: 31137785 DOI: 10.3390/ijms20102593] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
23 Vidimce J, Pillay J, Shrestha N, Dong LF, Neuzil J, Wagner KH, Holland OJ, Bulmer AC. Mitochondrial Function, Fatty Acid Metabolism, and Body Composition in the Hyperbilirubinemic Gunn Rat. Front Pharmacol 2021;12:586715. [PMID: 33762933 DOI: 10.3389/fphar.2021.586715] [Reference Citation Analysis]
24 Hinds TD Jr, Creeden JF, Gordon DM, Spegele AC, Britton SL, Koch LG, Stec DE. Rats Genetically Selected for High Aerobic Exercise Capacity Have Elevated Plasma Bilirubin by Upregulation of Hepatic Biliverdin Reductase-A (BVRA) and Suppression of UGT1A1. Antioxidants (Basel) 2020;9:E889. [PMID: 32961782 DOI: 10.3390/antiox9090889] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
25 Drummond HA, Mitchell ZL, Abraham NG, Stec DE. Targeting Heme Oxygenase-1 in Cardiovascular and Kidney Disease. Antioxidants (Basel) 2019;8:E181. [PMID: 31216709 DOI: 10.3390/antiox8060181] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
26 Marinovic M, Sousa-filho C, Batista F, Avelino T, Cogliati B, Figueira A, Otton R, Rodrigues A. Green tea extract increases adiponectin and PPARα levels to improve hepatic steatosis. The Journal of Nutritional Biochemistry 2022. [DOI: 10.1016/j.jnutbio.2022.108957] [Reference Citation Analysis]
27 Žiberna L, Jenko-Pražnikar Z, Petelin A. Serum Bilirubin Levels in Overweight and Obese Individuals: The Importance of Anti-Inflammatory and Antioxidant Responses. Antioxidants (Basel) 2021;10:1352. [PMID: 34572984 DOI: 10.3390/antiox10091352] [Reference Citation Analysis]
28 Novák P, Jackson AO, Zhao GJ, Yin K. Bilirubin in metabolic syndrome and associated inflammatory diseases: New perspectives. Life Sci 2020;257:118032. [PMID: 32621920 DOI: 10.1016/j.lfs.2020.118032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Vítek L. Bilirubin and atherosclerotic diseases. Physiol Res 2017;66:S11-20. [PMID: 28379026 DOI: 10.33549/physiolres.933581] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 6.2] [Reference Citation Analysis]
30 Adeosun SO, Moore KH, Lang DM, Nwaneri AC, Hinds TD Jr, Stec DE. A Novel Fluorescence-Based Assay for the Measurement of Biliverdin Reductase Activity. React Oxyg Species (Apex) 2018;5:35-45. [PMID: 29379885 DOI: 10.20455/ros.2018.809] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
31 Hinds TD Jr, Creeden JF, Gordon DM, Stec DF, Donald MC, Stec DE. Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate. Front Pharmacol 2020;11:594574. [PMID: 33390979 DOI: 10.3389/fphar.2020.594574] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
32 Weaver L, Hamoud AR, Stec DE, Hinds TD Jr. Biliverdin reductase and bilirubin in hepatic disease. Am J Physiol Gastrointest Liver Physiol 2018;314:G668-76. [PMID: 29494209 DOI: 10.1152/ajpgi.00026.2018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
33 Raffaele M, Barbagallo I, Licari M, Carota G, Sferrazzo G, Spampinato M, Sorrenti V, Vanella L. N-Acetylcysteine (NAC) Ameliorates Lipid-Related Metabolic Dysfunction in Bone Marrow Stromal Cells-Derived Adipocytes. Evid Based Complement Alternat Med 2018;2018:5310961. [PMID: 30416532 DOI: 10.1155/2018/5310961] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
34 Bianco A, Tiribelli C, Bellarosa C. Translational Approach to the Protective Effect of Bilirubin in Diabetic Kidney Disease. Biomedicines 2022;10:696. [DOI: 10.3390/biomedicines10030696] [Reference Citation Analysis]
35 Vítek L. Bilirubin as a signaling molecule. Med Res Rev 2020;40:1335-51. [PMID: 32017160 DOI: 10.1002/med.21660] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
36 Zhao MM, Krebs J, Cao X, Cui J, Chen DN, Li Y, Hua L, Mann J, Yang JK. Helicobacter pylori infection as a risk factor for serum bilirubin change and less favourable lipid profiles: a hospital-based health examination survey. BMC Infect Dis 2019;19:157. [PMID: 30764765 DOI: 10.1186/s12879-019-3787-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
37 Otterbein LE. Conquering Radicals with a Sense of Humor. Cell Chem Biol 2019;26:1335-7. [PMID: 31626781 DOI: 10.1016/j.chembiol.2019.10.001] [Reference Citation Analysis]
38 Wu SC, Chen TA, Cheng HT, Chang YJ, Wang YC, Tzeng CW, Hsu CH, Muo CH. Lipid-Free PN is Associated with an Increased Risk of Hyperbilirubinemia in Surgical Critically Ill Patients with Admission Hepatic Disorder: A Retrospective Observational Study. Ther Clin Risk Manag 2021;17:1001-10. [PMID: 34548793 DOI: 10.2147/TCRM.S322341] [Reference Citation Analysis]
39 Duvigneau JC, Esterbauer H, Kozlov AV. Role of Heme Oxygenase as a Modulator of Heme-Mediated Pathways. Antioxidants (Basel) 2019;8:E475. [PMID: 31614577 DOI: 10.3390/antiox8100475] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
40 Hana CA, Tran LV, Mölzer C, Müllner E, Hörmann-Wallner M, Franzke B, Tosevska A, Zöhrer PA, Doberer D, Marculescu R, Bulmer AC, Freisling H, Moazzami AA, Wagner KH. Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert's syndrome individuals. Metabolism 2021;125:154913. [PMID: 34653509 DOI: 10.1016/j.metabol.2021.154913] [Reference Citation Analysis]
41 Gazzin S, Masutti F, Vitek L, Tiribelli C. The molecular basis of jaundice: An old symptom revisited. Liver Int 2017;37:1094-102. [PMID: 28004508 DOI: 10.1111/liv.13351] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
42 Gabbia D, Saponaro M, Sarcognato S, Guido M, Ferri N, Carrara M, De Martin S. Fucus vesiculosus and Ascophyllum nodosum Ameliorate Liver Function by Reducing Diet-Induced Steatosis in Rats. Mar Drugs 2020;18:E62. [PMID: 31963560 DOI: 10.3390/md18010062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
43 Vítek L. Bilirubin as a predictor of diseases of civilization. Is it time to establish decision limits for serum bilirubin concentrations? Archives of Biochemistry and Biophysics 2019;672:108062. [DOI: 10.1016/j.abb.2019.108062] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
44 Chiu M, McBeth L, Sindhwani P, Hinds TD. Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer. PPAR Res 2017;2017:4810672. [PMID: 28348577 DOI: 10.1155/2017/4810672] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
45 Gordon DM, Hong SH, Kipp ZA, Hinds TD Jr. Identification of Binding Regions of Bilirubin in the Ligand-Binding Pocket of the Peroxisome Proliferator-Activated Receptor-A (PPARalpha). Molecules 2021;26:2975. [PMID: 34067839 DOI: 10.3390/molecules26102975] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Barbagallo I, Li Volti G, Galvano F, Tettamanti G, Pluchinotta FR, Bergante S, Vanella L. Diabetic human adipose tissue-derived mesenchymal stem cells fail to differentiate in functional adipocytes. Exp Biol Med (Maywood) 2017;242:1079-85. [PMID: 27909015 DOI: 10.1177/1535370216681552] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
47 Canesin G, Hejazi SM, Swanson KD, Wegiel B. Heme-Derived Metabolic Signals Dictate Immune Responses. Front Immunol 2020;11:66. [PMID: 32082323 DOI: 10.3389/fimmu.2020.00066] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
48 Thomas DT, Delcimmuto NR, Flack KD, Stec DE, Hinds TD. Reactive Oxygen Species (ROS) and Antioxidants as Immunomodulators in Exercise: Implications for Heme Oxygenase and Bilirubin. Antioxidants 2022;11:179. [DOI: 10.3390/antiox11020179] [Reference Citation Analysis]
49 Hinds TD Jr, Adeosun SO, Alamodi AA, Stec DE. Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor? Med Hypotheses 2016;95:54-7. [PMID: 27692168 DOI: 10.1016/j.mehy.2016.08.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
50 Nitti M, Furfaro AL, Mann GE. Heme Oxygenase Dependent Bilirubin Generation in Vascular Cells: A Role in Preventing Endothelial Dysfunction in Local Tissue Microenvironment? Front Physiol 2020;11:23. [PMID: 32082188 DOI: 10.3389/fphys.2020.00023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
51 Yao Q, Jiang X, Kou L, Samuriwo AT, Xu HL, Zhao YZ. Pharmacological actions and therapeutic potentials of bilirubin in islet transplantation for the treatment of diabetes. Pharmacol Res 2019;145:104256. [PMID: 31054312 DOI: 10.1016/j.phrs.2019.104256] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
52 Adeosun SO, Stec DE. Bilirubin protects the ageing heart. Acta Physiol (Oxf) 2017;220:402-3. [PMID: 28296151 DOI: 10.1111/apha.12873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
53 Stec DE, Gordon DM, Nestor-Kalinoski AL, Donald MC, Mitchell ZL, Creeden JF, Hinds TD Jr. Biliverdin Reductase A (BVRA) Knockout in Adipocytes Induces Hypertrophy and Reduces Mitochondria in White Fat of Obese Mice. Biomolecules 2020;10:E387. [PMID: 32131495 DOI: 10.3390/biom10030387] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
54 Lee H, Choi YK. Regenerative Effects of Heme Oxygenase Metabolites on Neuroinflammatory Diseases. Int J Mol Sci 2018;20:E78. [PMID: 30585210 DOI: 10.3390/ijms20010078] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
55 Gao H, Li Y, Chen X. Interactions between nuclear receptors glucocorticoid receptor α and peroxisome proliferator-activated receptor α form a negative feedback loop. Rev Endocr Metab Disord 2022. [PMID: 35476174 DOI: 10.1007/s11154-022-09725-w] [Reference Citation Analysis]
56 Chen W, Tumanov S, Fazakerley DJ, Cantley J, James DE, Dunn LL, Shaik T, Suarna C, Stocker R. Bilirubin deficiency renders mice susceptible to hepatic steatosis in the absence of insulin resistance. Redox Biol 2021;47:102152. [PMID: 34610553 DOI: 10.1016/j.redox.2021.102152] [Reference Citation Analysis]
57 Shi H, Feng Y, Jiang J, Zhao J, Li X, Liu X. Correlations between the serum bilirubin level and ulcerative colitis: a case-control study. Eur J Gastroenterol Hepatol 2019;31:992-7. [PMID: 31205128 DOI: 10.1097/MEG.0000000000001466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Vítek L. The Protective Role of the Heme Catabolic Pathway in Hepatic Disorders. Antioxid Redox Signal 2021. [PMID: 33906434 DOI: 10.1089/ars.2021.0080] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Floresta G, Carotti A, Ianni F, Sorrenti V, Intagliata S, Rescifina A, Salerno L, Di Michele A, Sardella R, Pittalà V. Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers. Bioorg Chem 2020;99:103777. [PMID: 32222619 DOI: 10.1016/j.bioorg.2020.103777] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
60 Takei R, Inoue T, Sonoda N, Kohjima M, Okamoto M, Sakamoto R, Inoguchi T, Ogawa Y. Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines. PLoS One 2019;14:e0223302. [PMID: 31577826 DOI: 10.1371/journal.pone.0223302] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
61 Cimini FA, Arena A, Barchetta I, Tramutola A, Ceccarelli V, Lanzillotta C, Fontana M, Bertoccini L, Leonetti F, Capoccia D, Silecchia G, Di Cristofano C, Chiappetta C, Di Domenico F, Baroni MG, Perluigi M, Cavallo MG, Barone E. Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity. Biochim Biophys Acta Mol Basis Dis 2019;1865:1490-501. [PMID: 30826467 DOI: 10.1016/j.bbadis.2019.02.021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
62 Kishimoto Y, Kondo K, Momiyama Y. The Protective Role of Heme Oxygenase-1 in Atherosclerotic Diseases. Int J Mol Sci 2019;20:E3628. [PMID: 31344980 DOI: 10.3390/ijms20153628] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
63 Mirończuk-Chodakowska I, Witkowska AM, Zujko ME. Endogenous non-enzymatic antioxidants in the human body. Adv Med Sci 2018;63:68-78. [PMID: 28822266 DOI: 10.1016/j.advms.2017.05.005] [Cited by in Crossref: 186] [Cited by in F6Publishing: 144] [Article Influence: 46.5] [Reference Citation Analysis]
64 Zhang F, Guan W, Fu Z, Zhou L, Guo W, Ma Y, Gong Y, Jiang W, Liang H, Zhou H. Relationship between Serum Indirect Bilirubin Level and Insulin Sensitivity: Results from Two Independent Cohorts of Obese Patients with Impaired Glucose Regulation and Type 2 Diabetes Mellitus in China. Int J Endocrinol 2020;2020:5681296. [PMID: 32802055 DOI: 10.1155/2020/5681296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
65 Gordon DM, Adeosun SO, Ngwudike SI, Anderson CD, Hall JE, Hinds TD Jr, Stec DE. CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation. Arch Biochem Biophys 2019;672:108072. [PMID: 31422074 DOI: 10.1016/j.abb.2019.108072] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
66 Li X, Yu D, Jie H, Zhou H, Ye H, Ma G, Wan L, Li C, Shi H, Yin S. Cytochrome P450 1A2 Is Incapable of Oxidizing Bilirubin Under Physiological Conditions. Front Pharmacol 2019;10:1220. [PMID: 31680983 DOI: 10.3389/fphar.2019.01220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
67 Vasavda C, Semenza ER, Liew J, Kothari R, Dhindsa RS, Shanmukha S, Lin A, Tokhunts R, Ricco C, Snowman AM, Albacarys L, Pastore F, Ripoli C, Grassi C, Barone E, Kornberg MD, Dong X, Paul BD, Snyder SH. Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signaling. Sci Signal 2022;15:eabh3066. [PMID: 35536885 DOI: 10.1126/scisignal.abh3066] [Reference Citation Analysis]
68 She QY, Bao JF, Wang HZ, Liang H, Huang W, Wu J, Zhong Y, Ling H, Li A, Qin SL. Fibroblast growth factor 21: A "rheostat" for metabolic regulation? Metabolism 2022;:155166. [PMID: 35183545 DOI: 10.1016/j.metabol.2022.155166] [Reference Citation Analysis]
69 Dkhil MA, Abdel Moneim AE, Hafez TA, Mubaraki MA, Mohamed WF, Thagfan FA, Al-Quraishy S. Myristica fragrans Kernels Prevent Paracetamol-Induced Hepatotoxicity by Inducing Anti-Apoptotic Genes and Nrf2/HO-1 Pathway. Int J Mol Sci 2019;20:E993. [PMID: 30823534 DOI: 10.3390/ijms20040993] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
70 Adeosun SO, Gordon DM, Weeks MF, Moore KH, Hall JE, Hinds TD, Stec DE. Loss of biliverdin reductase-A promotes lipid accumulation and lipotoxicity in mouse proximal tubule cells. Am J Physiol Renal Physiol. 2018;315:F323-F331. [PMID: 29631357 DOI: 10.1152/ajprenal.00495.2017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
71 Ryter SW. Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders. Antioxidants 2022;11:555. [DOI: 10.3390/antiox11030555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
72 Gordon DM, Blomquist TM, Miruzzi SA, McCullumsmith R, Stec DE, Hinds TD Jr. RNA sequencing in human HepG2 hepatocytes reveals PPAR-α mediates transcriptome responsiveness of bilirubin. Physiol Genomics 2019;51:234-40. [PMID: 31074682 DOI: 10.1152/physiolgenomics.00028.2019] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
73 Leng L, Ma J, Lv L, Gao D, Li M, Wang Y, Zhu Y. Serum proteome profiling provides a deep understanding of the 'gut-liver axis' in relation to liver injury and regeneration. Acta Biochim Biophys Sin (Shanghai) 2021;53:372-80. [PMID: 33511977 DOI: 10.1093/abbs/gmab001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Sundararaghavan VL, Sindhwani P, Hinds TD Jr. Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas? Oncotarget 2017;8:3640-8. [PMID: 27690298 DOI: 10.18632/oncotarget.12277] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
75 Rochette L, Zeller M, Cottin Y, Vergely C. Redox Functions of Heme Oxygenase-1 and Biliverdin Reductase in Diabetes. Trends Endocrinol Metab 2018;29:74-85. [PMID: 29249571 DOI: 10.1016/j.tem.2017.11.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 10.0] [Reference Citation Analysis]
76 Dvořák A, Pospíšilová K, Žížalová K, Capková N, Muchová L, Vecka M, Vrzáčková N, Křížová J, Zelenka J, Vítek L. The Effects of Bilirubin and Lumirubin on Metabolic and Oxidative Stress Markers. Front Pharmacol 2021;12:567001. [PMID: 33746746 DOI: 10.3389/fphar.2021.567001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
77 Fu J, Wang Q, Zhang L, Liu J, Wang G. Serum Bilirubin Level Is Increased in Metabolically Healthy Obesity. Front Endocrinol 2022;12:792795. [DOI: 10.3389/fendo.2021.792795] [Reference Citation Analysis]
78 Stec DE, Gordon DM, Hipp JA, Hong S, Mitchell ZL, Franco NR, Robison JW, Anderson CD, Stec DF, Hinds TD Jr. Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2019;317:R733-45. [PMID: 31483154 DOI: 10.1152/ajpregu.00153.2019] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
79 Gazzin S, Vitek L, Watchko J, Shapiro SM, Tiribelli C. A Novel Perspective on the Biology of Bilirubin in Health and Disease. Trends Mol Med 2016;22:758-68. [PMID: 27515064 DOI: 10.1016/j.molmed.2016.07.004] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 12.8] [Reference Citation Analysis]
80 Zhu YD, Guan XQ, Chen J, Peng S, Finel M, Zhao YY, Wang RM, Bi HC, Lei M, Wang DD, Ge GB. Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ. Front Pharmacol 2020;11:628314. [PMID: 33628187 DOI: 10.3389/fphar.2020.628314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 Hana CA, Klebermass EM, Balber T, Mitterhauser M, Quint R, Hirtl Y, Klimpke A, Somloi S, Hutz J, Sperr E, Eder P, Jašprová J, Valášková P, Vítek L, Heiss E, Wagner KH. Inhibition of Lipid Accumulation in Skeletal Muscle and Liver Cells: A Protective Mechanism of Bilirubin Against Diabetes Mellitus Type 2. Front Pharmacol 2020;11:636533. [PMID: 33569010 DOI: 10.3389/fphar.2020.636533] [Reference Citation Analysis]
82 Kim EY, Lee JM. Basal Autophagy Is Necessary for A Pharmacologic PPARα Transactivation. Cells 2022;11:754. [PMID: 35203398 DOI: 10.3390/cells11040754] [Reference Citation Analysis]
83 Stec DE, Wegiel B, Hinds TD Jr. Editorial: Oxidative Stress, Antioxidants, Transcription Factors, and Assimilation of Signal Transduction Pathways in Obesity-Related Disorders. Front Pharmacol 2021;12:759468. [PMID: 34557106 DOI: 10.3389/fphar.2021.759468] [Reference Citation Analysis]
84 Sanada S, Suzuki T, Nagata A, Hashidume T, Yoshikawa Y, Miyoshi N. Intestinal microbial metabolite stercobilin involvement in the chronic inflammation of ob/ob mice. Sci Rep 2020;10:6479. [PMID: 32296105 DOI: 10.1038/s41598-020-63627-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Vítek L, Tiribelli C. Bilirubin: The yellow hormone? J Hepatol 2021:S0168-8278(21)00425-6. [PMID: 34153399 DOI: 10.1016/j.jhep.2021.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Seyed Khoei N, Grindel A, Wallner M, Mölzer C, Doberer D, Marculescu R, Bulmer A, Wagner KH. Mild hyperbilirubinaemia as an endogenous mitigator of overweight and obesity: Implications for improved metabolic health. Atherosclerosis 2018;269:306-11. [PMID: 29279144 DOI: 10.1016/j.atherosclerosis.2017.12.021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
87 Tayyeb JZ, Popeijus HE, van de Sanden J, Zwaan W, Mensink RP, Plat J. Effects of Individual Amino Acids on PPARα Transactivation, mTORC1 Activation, ApoA-I Transcription and pro-ApoA-I Secretion. IJMS 2022;23:6071. [DOI: 10.3390/ijms23116071] [Reference Citation Analysis]
88 Kuciel-Lewandowska J, Kasperczak M, Bogut B, Heider R, Laber WT, Laber W, Paprocka-Borowicz M. The Impact of Health Resort Treatment on the Nonenzymatic Endogenous Antioxidant System. Oxid Med Cell Longev 2020;2020:8423105. [PMID: 32089783 DOI: 10.1155/2020/8423105] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
89 Gordon DM, Neifer KL, Hamoud AA, Hawk CF, Nestor-Kalinoski AL, Miruzzi SA, Morran MP, Adeosun SO, Sarver JG, Erhardt PW, McCullumsmith RE, Stec DE, Hinds TD Jr. Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor α. J Biol Chem 2020;295:9804-22. [PMID: 32404366 DOI: 10.1074/jbc.RA120.013700] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
90 Bulmer AC, Bakrania B, Du Toit EF, Boon AC, Clark PJ, Powell LW, Wagner KH, Headrick JP. Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea. Am J Physiol Heart Circ Physiol 2018;315:H429-47. [PMID: 29600900 DOI: 10.1152/ajpheart.00417.2017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
91 Šuk J, Jašprová J, Biedermann D, Petrásková L, Valentová K, Křen V, Muchová L, Vítek L. Isolated Silymarin Flavonoids Increase Systemic and Hepatic Bilirubin Concentrations and Lower Lipoperoxidation in Mice. Oxid Med Cell Longev 2019;2019:6026902. [PMID: 30891115 DOI: 10.1155/2019/6026902] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
92 McClung JA, Levy L, Garcia V, Stec DE, Peterson SJ, Abraham NG. Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications. Pharmacol Ther 2021;:107975. [PMID: 34499923 DOI: 10.1016/j.pharmthera.2021.107975] [Reference Citation Analysis]
93 Wen G, Yao L, Hao Y, Wang J, Liu J. Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system. J Transl Med 2022;20:1. [PMID: 34980160 DOI: 10.1186/s12967-021-03207-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Ge X, Liu Z, Hou Q, Huang L, Zhou Y, Li D, Huang S, Luo X, Lv Y, Li L, Cheng H, Chen X, Zan G, Tan Y, Liu C, Zou Y, Yang X. Plasma metals and serum bilirubin levels in workers from manganese-exposed workers healthy cohort (MEWHC). Environ Pollut 2020;258:113683. [PMID: 31838386 DOI: 10.1016/j.envpol.2019.113683] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
95 Hinds TD Jr, Stec DE. Bilirubin Safeguards Cardiorenal and Metabolic Diseases: a Protective Role in Health. Curr Hypertens Rep 2019;21:87. [PMID: 31599366 DOI: 10.1007/s11906-019-0994-z] [Cited by in F6Publishing: 14] [Reference Citation Analysis]